| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Paul Michael Blakeley, Lauren Emma Capron, Anna Bugge Jensen, Kieran J O'Donnell, Vivette Glove. Maternal prenatal symptoms of depression and down regulation of placental monoamine oxidase A expression. Journal of psychosomatic research. vol 75. issue 4. 2014-06-23. PMID:24119940. |
the current study aimed to determine whether maternal symptoms of depression or anxiety were associated with decreased placental expression of monoamine oxidase a (mao a), the enzyme which metabolises 5-ht into 5-hydroxyindoleacetic acid. |
2014-06-23 |
2023-08-12 |
Not clear |
| Raimo K R Salokangas, Jukka Huttunen, Jarmo Hietal. Discontinuation of citalopram medication and striatal dopamine activity. International journal of psychiatry in clinical practice. vol 10. issue 4. 2014-06-20. PMID:24941151. |
a 35-year-old caucasian woman who suffered from major depression with marked psychomotor symptoms was treated with a selective serotonin re-uptake inhibitor (ssri), citalopram. |
2014-06-20 |
2023-08-13 |
Not clear |
| Duru Gundogar, Serpil Demirci, Filiz Uluha. How should we inform patients about antidepressants? A study comparing verbal and written information. International journal of psychiatry in clinical practice. vol 11. issue 3. 2014-06-20. PMID:24941360. |
to compare the efficacy of verbal, written and, combined verbal and written information about selective serotonin reuptake inhibitors in patients with depression. |
2014-06-20 |
2023-08-13 |
Not clear |
| Duru Gundogar, Serpil Demirci, Filiz Uluha. How should we inform patients about antidepressants? A study comparing verbal and written information. International journal of psychiatry in clinical practice. vol 11. issue 3. 2014-06-20. PMID:24941360. |
patients with a diagnosis of major depression who were prescribed selective serotonin reuptake inhibitors (n=104) were randomly allocated to verbal (n=34, 18f 16m), written (n=38, 19f 19 m) and verbal and written information (n=32, 18f 14m) groups, the content of the verbal and written information being exactly the same. |
2014-06-20 |
2023-08-13 |
Not clear |
| Duru Gundogar, Serpil Demirci, Filiz Uluha. How should we inform patients about antidepressants? A study comparing verbal and written information. International journal of psychiatry in clinical practice. vol 11. issue 3. 2014-06-20. PMID:24941360. |
the retention of verbal information given to patients with low levels of depression concerning the effects and side effects of serotonin reuptake inhibitors is higher than written information. |
2014-06-20 |
2023-08-13 |
Not clear |
| Stefano Pallanti, Cláudio Sandne. Treatment of depression with selective serotonin inhibitors: the role of fluvoxamine. International journal of psychiatry in clinical practice. vol 11. issue 3. 2014-06-20. PMID:24941363. |
treatment of depression with selective serotonin inhibitors: the role of fluvoxamine. |
2014-06-20 |
2023-08-13 |
Not clear |
| Stefano Pallanti, Cláudio Sandne. Treatment of depression with selective serotonin inhibitors: the role of fluvoxamine. International journal of psychiatry in clinical practice. vol 11. issue 3. 2014-06-20. PMID:24941363. |
the advent of the selective serotonin reuptake inhibitors (ssris) is generally considered to have improved the treatment of depression. |
2014-06-20 |
2023-08-13 |
Not clear |
| F Rouillo. Depression comorbid with anxiety or medical illness: The role of paroxetine. International journal of psychiatry in clinical practice. vol 5. issue 1. 2014-06-19. PMID:24936987. |
the selective serotonin re-uptake inhibitor paroxetine has proven efficacy in the treatment of depression and anxiety disorders, including panic disorder, obsessive compulsive disorder and social anxiety disorder. |
2014-06-19 |
2023-08-13 |
Not clear |
| Tetsuhiro Maruyam. New treatment of depression in Parkinson's disease. International journal of psychiatry in clinical practice. vol 7 Suppl 1. 2014-06-19. PMID:24937417. |
tricyclic antidepressants (tca) and selective serotonin reuptake inhibitors (ssri) have been used to treat depression associated with parkinson's disease. |
2014-06-19 |
2023-08-13 |
Not clear |
| Shouhei Nagaoka, Mikako Ohno, Akiko Sekiguch. An open-label clinical trial of milnacipran in fibromyalgia syndrome with co-morbid depressive symptoms. International journal of psychiatry in clinical practice. vol 8. issue 1. 2014-06-19. PMID:24937583. |
to evaluate the efficacy of the serotonin and noradrenaline reuptake inhibiting antidepressant, milnacipran, in patients with fibromyalgia syndrome and co-morbid depression. |
2014-06-19 |
2023-08-13 |
Not clear |
| Oscar Andrés Moreno-Ramos, Maria Claudia Lattig, Andrés Fernando González Barrio. Modeling of the hypothalamic-pituitary-adrenal axis-mediated interaction between the serotonin regulation pathway and the stress response using a Boolean approximation: a novel study of depression. Theoretical biology & medical modelling. vol 10. 2014-06-18. PMID:24093582. |
modeling of the hypothalamic-pituitary-adrenal axis-mediated interaction between the serotonin regulation pathway and the stress response using a boolean approximation: a novel study of depression. |
2014-06-18 |
2023-08-12 |
Not clear |
| Xue Deng, Lu Ren, Jing Li, Jian-Duan Sun, Shen-Kang Fu, Shou-Zhang Zha. [Effect of electroacupuncture stimulation of "Ganshu" (BL 18) on locomotor, gastric mucosal and hypothalamic SP immunoactivity and hippocampal 5-HT content in rats with depression and gastric ulcer]. Zhen ci yan jiu = Acupuncture research. vol 39. issue 2. 2014-06-17. PMID:24818496. |
[effect of electroacupuncture stimulation of "ganshu" (bl 18) on locomotor, gastric mucosal and hypothalamic sp immunoactivity and hippocampal 5-ht content in rats with depression and gastric ulcer]. |
2014-06-17 |
2023-08-13 |
rat |
| Xue Deng, Lu Ren, Jing Li, Jian-Duan Sun, Shen-Kang Fu, Shou-Zhang Zha. [Effect of electroacupuncture stimulation of "Ganshu" (BL 18) on locomotor, gastric mucosal and hypothalamic SP immunoactivity and hippocampal 5-HT content in rats with depression and gastric ulcer]. Zhen ci yan jiu = Acupuncture research. vol 39. issue 2. 2014-06-17. PMID:24818496. |
to observe the effect of electroacupuncture (ea) stimulation of "ganshu" (bl18) on expression of substance p (sp) in the gastric mucosa and hypothalamus tissues and hippocampal 5-hydroxytryptamine (5-ht) content in rats with depression + gastric ulcer, so as to explore its mechanism underlying improvement of depressive gastric ulcer. |
2014-06-17 |
2023-08-13 |
rat |
| Ken Wada, Hiroshi Suzuki, Toshihiro Taira, Kazufumi Akiyama, Shigetoshi Kurod. Successful use of intravenous clomipramine in depressive-catatonic state associated with corticosteroid treatment. International journal of psychiatry in clinical practice. vol 8. issue 2. 2014-06-17. PMID:24926847. |
clomipramine, a tricyclic antidepressant with relatively stronger serotonin reuptake inhibition, is one of the useful treatment options for corticosteroid-induced depression even in severe cases. |
2014-06-17 |
2023-08-13 |
Not clear |
| Zheng-Li Zhou, Hsuan-Liang Liu, Josephine W Wu, Cheng-Wen Tsao, Wei-Hsi Chen, Kung-Tien Liu, Yih H. Combining structure-based pharmacophore and in silico approaches to discover novel selective serotonin reuptake inhibitors. Chemical biology & drug design. vol 82. issue 6. 2014-06-16. PMID:23865625. |
inhibition of human serotonin transporter (hsert) has been reported to be a potent strategy for the treatment for depression. |
2014-06-16 |
2023-08-12 |
human |
| Charlotte Björkenstam, Jette Möller, Gunilla Ringbäck, Peter Salmi, Johan Hallqvist, Rickard Ljun. An association between initiation of selective serotonin reuptake inhibitors and suicide - a nationwide register-based case-crossover study. PloS one. vol 8. issue 9. 2014-06-15. PMID:24040131. |
treatment with selective serotonin reuptake inhibitors (ssri) is one of the most common treatments for depression. |
2014-06-15 |
2023-08-12 |
Not clear |
| Stuart Montgomer. Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant development. International journal of psychiatry in clinical practice. vol 10 Suppl 2. 2014-06-14. PMID:24921676. |
the introduction of the ssris naturally focussed both fundamental and clinical research effort on the role of serotonin (5-ht) in the pharmacogenesis and pharmacotherapy of depression. |
2014-06-14 |
2023-08-13 |
Not clear |
| B D Sachs, J P R Jacobsen, T L Thomas, W B Siesser, W L Roberts, M G Caro. The effects of congenital brain serotonin deficiency on responses to chronic fluoxetine. Translational psychiatry. vol 3. 2014-06-05. PMID:23942622. |
overall, these findings shed new light on the impact of 5-ht deficiency on responses to flx and may have important implications for treatment selection in depression and anxiety disorders. |
2014-06-05 |
2023-08-12 |
mouse |
| K Oved, A Morag, M Pasmanik-Chor, M Rehavi, N Shomron, D Gurwit. Genome-wide expression profiling of human lymphoblastoid cell lines implicates integrin beta-3 in the mode of action of antidepressants. Translational psychiatry. vol 3. 2014-06-05. PMID:24129413. |
selective serotonin reuptake inhibitors (ssris) are the first-line treatment for major depression. |
2014-06-05 |
2023-08-12 |
human |
| K Oved, A Morag, M Pasmanik-Chor, M Rehavi, N Shomron, D Gurwit. Genome-wide expression profiling of human lymphoblastoid cell lines implicates integrin beta-3 in the mode of action of antidepressants. Translational psychiatry. vol 3. 2014-06-05. PMID:24129413. |
however, the link between inhibition of serotonin reuptake and remission from depression remains controversial: in spite of the rapid onset of serotonin reuptake inhibition, remission from depression takes several weeks, presumably reflecting synaptogenesis/neurogenesis and neuronal rewiring. |
2014-06-05 |
2023-08-12 |
human |